Big data in IBD: big progress for clinical practice

Nasim Sadat Seyed Tabib(KU Leuven), Séverine Vermeire(KU Leuven), Tamás Korcsmáros(Eötvös Loránd University), Bram Verstockt(Universitair Ziekenhuis Leuven), Matthew Madgwick(Quadram Institute), Padhmanand Sudhakar(KU Leuven)

Gut

February 28, 2020

10.1136/gutjnl-2019-320065

Cited by 225

Related Papers

Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease

|Nature Genetics|2008|2.6k

A decrease of the butyrate-producing species <i>Roseburia hominis</i> and <i>Faecalibacterium prausnitzii</i> defines dysbiosis in patients with ulcerative colitis

|Gut|2013|1.9k

ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications

|Journal of Crohn s and Colitis|2018|1.8k

Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease

|New England Journal of Medicine|2016|1.8k

ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment

|Journal of Crohn s and Colitis|2019|1.4k